 |
EDITORIAL
Obesity — a modifiable risk factor
René Lerch |
|
BASIC
ARTICLE
The brain and regulation of body weight
Randy J. Seeley, Stephen C. Woods |
|
MAIN
CLINICAL ARTICLE
Obesity and cardiovascular disease
Martin A. Alpert |
|
IMAGING
Echocardiographic and hemodynamic data in obese patients
Heribert Schunkert |
|
NEW
THERAPEUTIC APPROACHES
Diets, medications, and surgery
Maria L. Collazo-Clavell |
|
FOCUS
ON TRIMETAZIDINE (VASTAREL)
Rationale for a metabolic intervention in obese patients with
coronary heart disease
Ioana Holban, P. Goldenberg |
|
CASE
REPORT
Helping your patients confront their cardiovascular risk
Alain Golay, Francesca Amati, Annick
Riecker-Agranier, J. Ybarra |
|
REFRESHER
CORNER
Physiology and pathophysiology of energy storage
Gema Frühbeck |
|
FEATURED
RESEARCH
- Alterations of the circadian clock in the heart by streptozotocin-induced
diabetes
- Adiponectin, metabolic risk factors, and cardiovascular
events among patients with end-stage renal disease
- Predictive value of the adipocyte-derived plasma protein
adiponectin for restenosis after elective coronary stenting
- Reduction in the incidence of type 2 diabetes with lifestyle
intervention or metformin |
|
GLOSSARY
Gary D. Lopaschuk |
|
ALL
ARTICLES AS PDF FILE
For easy printing and true layout; to be viewed with
free Adobe®
Acrobat® Reader® |
